Download Docs
Export
Print

NCRTX

50162905 | Trademark citeCite Docket

Interested in this case?

To schedule a demo, contact us at sales@docketalarm.com. Track this case, and find millions of cases like it, let us show you how.
Filed Oct. 15, 2026
Serial No. 50162905
Examining Attorney null
Class Therapeutic agent for medical purposes, namely, for treatment of central nervous system disorders, cancers, and inflammatory diseases; pharmaceutical therapeutic preparations for medical use, namely, treatment of central nervous system disorders, cancers, and inflammatory diseases; pharmaceutical therapeutic preparations for use in the treatment of neurodegenerative amyloid diseases; pharmaceutical preparations for treatment of central nervous system disorders, cancers, and inflammatory diseases; diagnostic agent for medical purposes; diagnostic agent for medical use, namely, diagnostic agent for in vivo use; pharmaceutical diagnostic preparations for medical use; pharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative amyloid diseases; pharmaceutical preparations for detection and diagnosis of central nervous system disorders, cancers, and inflammatory diseases; imaging agents for magnetic resonance imaging (MRI); 005; 006; 018; 044; 046; 051; 052
NCRTX
Case Type Trademark
Status New application awaiting assignment to an examining attorney. <a href="https://www.uspto.gov/dashboard/trademarks/application-timeline.html">See current trademark processing wait times </a> for more information.
Last Updated: 2 weeks, 2 days ago
Filing Date # Docket Text
to view the full docket.